ElKabbany ZA, Ismail EAR, Hamed ET, Elbarbary NS, et al. The impact of vildagliptin as an add-on therapy on matrix metalloproteinase-14 levels, liver stiffness and subclinical atherosclerosis in adolescents with type 1 diabetes and non-alcoholic steatohepatitis: A randomized controlled trial. Diabetes Obes Metab 2024 Sep 24. doi: 10.1111/dom.15958.
PMID: 39318059